Atlas Trials

Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer

Clinical trial NCT01627379 · TERMINATED

Trial details

NCT number
NCT01627379
Sponsor
AIO-Studien-gGmbH
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Esophageal Squamous Cell Cancer
Start date
2012-05-01
Primary completion
2015-05-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.